Quick Answer
GeneDx Holdings Corp. reported Shares Outstanding of 29.25 million shares for fiscal year 2025.
GeneDx Holdings Corp. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 29.25M | +4.4% |
| 2024 | 28.02M | +7.8% |
| 2023 | 25.98M | +120.7% |
| 2022 | 11.77M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 28.89M | +5.3% | +0.6% |
| June 30, 2025 | 28.71M | +6.6% | +0.6% |
| March 31, 2025 | 28.53M | +9.2% | +1.8% |
| December 31, 2024 | 28.02M | +7.8% | +2.1% |
| September 30, 2024 | 27.43M | +6.0% | +1.9% |
| June 30, 2024 | 26.93M | +4.5% | +3.1% |
| March 31, 2024 | 26.12M | +8.0% | +0.6% |
| December 31, 2023 | 25.98M | +120.7% | +0.4% |
- GeneDx Holdings Corp. showed an increase of +4.4% in Shares Outstanding compared to the prior fiscal year.
- Over the 2022–2025 period, GeneDx Holdings Corp.’s shares outstanding has grown by 148.4% (from 11.77 million shares to 29.25 million shares).
- The most recent figure is from GeneDx Holdings Corp.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: